drugset

drugset / Trial / NCT00023530

Blood and Marrow Transplant Clinical Research Network

NCT00023530 ↗

Completed National Heart, Lung, and Blood Institute (NHLBI) Blood and Marrow Transplant Clinical Trials Network · collab

RandomizedDouble-blindPrevention

Summary

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Timeline

Start: 2001-09
Primary completion: —
Completion: 2006-08

Publications

Background Wingard JR. Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation. Clin Infect Dis. 2004 Oct 15;39 Suppl 4:S176-80. doi: 10.1086/421953.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	—	—
Subject	Fluconazole	Small molecule	—	—
Subject	Thalidomide	Other / unclassified	—	—
Subject	Voriconazole	Small molecule	—	—

Indications